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Osteoporosis is a global health problem characterised by low bone mass and an increase in 
bone fragility. It is now well accepted that dietary factors play a central role in bone 
development and health. Diet that lacks adequate minerals is considered to be a risk factor 
for osteoporosis. The food supplement, Aquamin, is a natural, multi-mineral derived from 
the red algae Lithothamnion corallioides, rich in calcium, magnesium and 72 other trace 
minerals. The aim of this study was to evaluate the effect of Aquamin on osteoblastic 
behaviour and mineralisation in a pre-osteoblastic cell line. Cell number and metabolic 
activity were assessed using Hoescht DNA and Alamar Blue assays respectively. 
Osteogenic differentiation was measured using an alkaline phosphatase assay while 
mineralisation was determined using von Kossa and alizarin red staining. It is reported here 
that Aquamin promotes increased mineralisation in osteoblast cell culture. These data 
suggest that the nutritional supplement, Aquamin plays an important role in promoting 










































































Osteoporosis is a condition characterised by low bone mass, low mineral content and 
microarchitectural deterioration leading to enhanced bone fragility and consequent increase 
in risk of bone fracture (Raisz 2005). Dietary factors are known to play an important role in 
bone health determining final bone mineral density and the extent of age-related bone-loss 
in later life (Palacios 2006). Diets lacking adequate inorganic minerals, especially calcium, 
have been identified as risk factors for osteoporosis (Peacock et al., 2000). Although 
calcium is considered to be the most important mineral in bone, several other minerals are 
also known to play a major role in bone health including magnesium, manganese, copper, 
zinc and selenium (Nieves 2005; Palacios 2006). It is now accepted that many individuals 
who do not obtain the recommended daily amount (RDA) of these minerals from dietary 
sources depend on calcium and multi-mineral supplements. 
Aquamin is a natural, marine-derived, multi-mineral rich in calcium and magnesium as well 
as measurable levels of 72 other minerals including manganese, selenium, copper and zinc. 
It is harvested from the skeletal remains of the red marine algae Lithothamnion corallioides 
from the cold Atlantic waters off the coasts of Ireland and Iceland. 
Poor diets, especially those that contain a high proportion of fat, have been identified as 
risk factors for osteoporosis (Wohl et al., 1998). In a recent 15 month study, mice were fed 
normal chow, a high fat western style diet (HFWD), or HFWD plus Aquamin. Results 
showed that HFWD mice lost a significant amount of bone compared to control mice, and 
that Aquamin reversed the negative effects of the HFWD (Aslam et al., 2010a).  The 
authors were unable to identify why exactly Aquamin preserved bone structure and 
































































function in the mice other than stating that many of the individual components of Aquamin 
have a direct effect on bone structure and function. However, they hypothesised that the 
positive effects of Aquamin on bone may also be a secondary response to the control of 
systemic inflammation by Aquamin. 
Whether a direct result or as a secondary response Aquamin has also been shown to alter 
markers of bone metabolism in yearling horses (Nielsen et al., 2010). Treatment with 
Aquamin resulted in an increase in osteocalcin, a marker of bone formation. In conjunction 
with this was an increase in C-telopeptide crosslaps of type I collagen, a bone resorption 
marker. This enhanced bone turnover may provide a means to remove and repair old or 
damaged bone which is essential in maintaining bone health. As calcium is the main 
constituent of Aquamin it is possible that the calcium present stimulates the production of 
bone morphogenic proteins which increase proliferation of osteoblasts (Nakade et al., 
2001).   
Aquamin has also been shown to be of benefit in joint health (Frestedt et al., 2008; Frestedt 
et al., 2009). Two randomised, double-blind, placebo-controlled studies using Aquamin 
showed reduction of osteoarthritic symptoms and increased activity scores in subjects with 
moderate to severe osteoarthritis. It was proposed that this was mediated through tumor 
necrosis factor alpha, a cytokine involved in systemic inflammation, and  interleukin 1β, a 
cytokine involved in the inflammatory response (Ryan et al., 2010). Finally, in digestive 
health a recent in-vitro study described the growth inhibitory effects of Aquamin on 
calcium-sensitive and calcium-resistant colon carcinoma cells (Aslam et al., 2009). Another 
































































study showed how Aquamin inhibits polyp formation and inflammation in the 
gastrointestinal tract of mice on a HFWD diet (Aslam et al., 2010b).  
Osteoblasts play an essential role in bone metabolism and new bone formation (Parfitt 
1984). Osteoblasts differentiate from mesenchymal cells and are responsible for the 
synthesis of bone matrix and bone mineralization, synthesis of growth factors and 
hormones and also for the regulation of osteoclastogenesis and bone resorption. The present 
study was conducted to examine the effect of Aquamin on osteoblastic behaviour and 
mineralisation in the mouse calvarial pre-osteoblastic MC3T3-E1 cell line. This cell line 
has the ability to differentiate into mature osteoblast phenotype and to mineralise in the 
presence of β-glycerophosphate and ascorbic acid (Menard et al., 2000).  
In this study we test the hypothesis that Aquamin directly enhances osteogenesis by 
providing not only an extra source of calcium but also other essential bone supporting 
minerals necessary for the mineralisation of extra cellular matrix deposited by these cells.  
 
Materials and Methods 
Aquamin: This study employed the soluble form of Aquamin containing 12% calcium and 
1% magnesium as well as trace quantities of other bone-supporting minerals including 
manganese, selenium, copper and zinc as described recently (Aslam et al., 2010a). The 
mineralised fronds of the red marine algae Lithothamnion corallioides are prepared under 
ISO and HACCP certification and sold as Aquamin® (EU and FDA approved, GRAS 
000028) (Marigot Ltd, Cork, Ireland).  
































































The experimental dose for Aquamin (1mg/ml) was obtained from preliminary experiments 
which examined the pH of dose media, cell metabolic activity and cell number/viability in 
MC3T3-E1 cells (data not shown). Similar concentrations were used in previous 
experiments using low passage human dermal fibroblasts, colon carcinoma cell lines 
(Aslam et al., 2009) and cortical glial-enriched primary cultures (Ryan et al., 2010). 
Unless otherwise stated, all consumables and chemicals were purchased from Sigma-
Aldrich (Germany). 
Cell Culture: This study was carried out in 2D using 6-well plates and 22mm discs. 
MC3T3-E1 murine calvarial osteoblasts were maintained in α-modified MEM 
supplemented with 10% fetal bovine serum, 1% L-glutamine and 2% 
penicillin/streptomycin. The media was replaced every 3-4 days. Cells were detached using 
trypsin-EDTA, centrifuged at 500g for 5 minutes at 20°C and re-suspended to obtain a 
seeding density of 50,000 cells per disc. Osteogenic media was prepared with the addition 
of ascorbic acid (50µg/ml), β-glycerophosphate (10mM), dexamethasone (100nM) and 
Aquamin (Marigot Ltd., Cork, Ireland) at a dose of 1mg/ml to standard medium. An 
osteogenic media without the addition of Aquamin was used as a control.  
Metabolic Activity: Osteoblast activity was evaluated using AlamarBlue (Invitrogen) as 
described previously (O'Brien et al., 2000). 4mls of supplemented α-MEM media 
containing 10% alamarBlue solution was placed into each well at 24 hours and placed in a 
37°C incubator with 5% CO2. After 2.5 hours the plates were removed from the incubator 
and 100µl of the reduced alamarBlue supernatant was plated out in triplicate into a 96-well 
































































plate and absorbance of the samples was read on a spectrometer (Titertrek Multiscan, MSC, 
Ireland) at 540nm and 620nm. Percentage reduction of the alamarBlue solution was 
determined according to the manufacturer’s specifications. This method was repeated at 
every time point up to 28 days.  
Cell Number: Cell number was determined using a DNA assay, Hoechst 33258 according 
to a previously published protocol (Kim et al., 1988). Cells were detached using trypsin-
EDTA. 3mls of media was added to each well and the cell suspension centrifuged at 500g 
for 5 minutes. The cell pellet was then re-suspended in 400µl papain buffer solution 
(100mls DPBS, 1ml 0.5M EDTA (pH 8.0), 79ml Cysteine-HCl; 10mg papain per 10ml 
buffer), transferred to eppendorfs and incubated at 60°C for 40 minutes. A 10x solution of 
Hoechst buffer was made: 10mM Tris, 10mM Na2EDTA, 1M NaCl; pH 7.4 and filter 
sterilised. A working dye concentration was freshly made for each experiment at 0.1µg per 
ml (1:10,000) dilution – 2mls 10x Hoechst buffer, 18mls distilled water, 2µl Hoechst stock 
dye and protected from light. Once cell suspension had been fully digested, 30µl of each 
sample was mixed with 600µl of working dye solution and vortexed briefly. The resulting 
solution was plated out in triplicate and read at an excitation of 355nm and an emission of 
460nm (Wallac Victor, PerkinElmer Life Sciences). Readings were converted to cell 
number by standard curve. Controls were measured as blank scaffold samples digested in 
papain. These experiments were repeated to provide a sample of n=3 for each time point for 
28 days.  
Alkaline Phosphatase Expression (ALP): ALP was chosen as a marker of early bone 
formation and measured using a p-nitrophenyl phosphate (pNPP) assay as per 
































































manufacturer’s instructions. 2mls of ALP lysis buffer (0.1M sodium acetate anhydrous, 2% 
triton-X 100®, 10mM pNPP solution) was added to each well and the plates incubated in 
the dark at 37°C for 1 hour. 200µl of the resulting supernatant was plated in triplicate into a 
96-well plate. 100µl of 0.3M NaOH  was added to each well to stop the reaction and the 
plates were read on a spectrometer (Titertrek MultiScan, MSC, Ireland) at 405nm at each 
time point and this was repeated to obtain n=3 for all time points.  The results are presented 
with ALP expression normalised to cell number evaluated from the DNA assay,  
Mineralisation Staining: Mineralisation was detected using von Kossa staining and was 
quantified with alizarin red absorbance readings. These techniques are used routinely in our 
laboratory (Gleeson et al., 2010) . 
Von Kossa Staining: Cells were stained for the presence of mineralisation with Von Kossa 
stain which is highly specific for calcium/phosphate deposition. Disc sections over the 28 
days were prepared for staining and re-hydrated through a series of ethanol/distilled water 
baths. Once the sections had been re-hydrated, 5% silver nitrate solution was pipetted onto 
the surface of the disc and left under a lamp source for 1 hour. Discs were washed 3 times 
in distilled water and incubated with sodium thiosulphate for 2 mins. Discs were again 
washed and stained with toluidine blue as background staining for cells and dehydrated, air-
dried and cover-slipped before being viewed under light microscopy. 
Alizarin Red S Staining: Disc sections were stained with Alizarin Red S at the specified 
time intervals over the 28 day culture period. Alizarin red S attaches non-specifically to 
calcium and is used to observe if bone mineral has been deposited. Sections were re-
































































hydrated through a series of ethanol/distilled water baths. Once sections had been re-
hydrated, slides were placed into a bath containing 2% alizarin red S and left for 2 mins. 
Sections were dehydrated back through water/ethanol but were left to dry completely 
without cover slip addition. A 10% acetylpyridinium chloride solution was made by 
dissolving the powder in distilled water by heating while stirring. 1ml of the resulting 
solution was added to each well. Plates were gently agitated on a rocker for 20 minutes. A 
100µl of the solution was pipetted in triplicate into a 96-well plate and read at 540nm. This 
was repeated for n=3 for all time points up to 28 days.            
Statistical Analysis: One-way ANOVA was used in all analyses with Holm-Sidak t-test 
used for multiple comparisons. Statistical significance was determined at p<0.05.  

































































Cellular metabolic activity increased in both the untreated and Aquamin-treated groups 
over the course of the culture period. Statistically higher levels of metabolic activity 
(p<0.047) were seen at days 14, 21 and 28 relative to the earlier time points in both groups 
(Figure 1A). No difference in metabolic activity was found between the control and 
Aquamin-treated groups at any time point.  
 
Statistical analysis indicated (p<0.042) that cell number was significantly increased by days 
14, 21 and 28 relative to the earlier time points of days 1, 3 and 7 in both groups (Figure 
1B). Cell number at day 21 in the control group exhibited the highest cell number during 
the culture period and was statistically higher (p<0.016) relative to all other groups and 
time points.  
 
No ALP expression was found at day 1 while peak expression occurred at day 3 in both 
groups (Figure 2) with significantly higher expression found at days 3 and 7 than at days 1, 
14, 21 and 28 in both groups (p≤0.005). Notably, expression of ALP was significantly 
higher in the Aquamin-treated group compared to the control at day 21 (p≤0.05) with no 
difference found at any of the other time points. 
 
Control and Aquamin-treated discs were evaluated for calcium deposits using Von Kossa 
which labels deposits of calcium with silver nitrate (Figure 3). Toluidine blue staining was 
































































used for background visualisation of the cell layer. Red arrows show cell nodule formation 
occurring among the cell layer. Deposits of calcium were first seen at Day 21 in the control 
and Aquamin-treated group (Figure 3, G and H) and continued to day 28. Nodule formation 
occurred as the culture period increased and osteoblasts tended to layer themselves within 
these nodules. Mineral was first detected in these cell nodules. 
 
Mineral deposition was also evaluated using alizarin red S at each time point. Small 
nodules of red-stained mineral appeared on all Aquamin-treated discs at day 14 (Figure. 
4A, F) and continued to increase until staining was completely wide-spread throughout the 
cell layer (Figure 4A, H and J). Small mineral deposits were seen at day 14 in the control 
group; however mineral deposition did not increase dramatically during the culture period 
up to day 28 and remained sparse when compared to the Aquamin-treated group. The cell 
layer in all groups tended to form cell nodules as the culture period increased and the cells 
started to layer themselves on each other. It is in these cell nodules that the mineral 
deposition tends to occur first.   
When quantified, mineral deposition was seen to increase linearly over time in both groups 
with no statistical effect observed between groups until day 28.  At this time point 
statistical analysis indicated that Aquamin resulted in increased mineral deposition (p< 
0.001) (Figure 4B).  

































































In this study we assessed the effects of the marine-derived, multi-mineral, Aquamin on 
osteoblast behaviour and mineralisation in the mouse calvarial pre-osteoblastic MC3T3-E1 
cell line. Aquamin (EU and FDA approved, GRAS 000028) is sold globally by Marigot 
Ltd., Ireland following harvesting of Lithothamnion corallioides. The mineralised fronds 
are rich in calcium and magnesium and other essential minerals required for bone health 
including manganese, zinc, copper, selenium, phosphorous and boron (Nieves 2005).  It 
was hypothesized that Aquamin, with its rich mineral supply, would have a positive 
osteogenic effect on the cellular behaviour and mineralising capacity of osteoblasts. This 
study showed that Aquamin does not have any cytotoxic effect and possesses the ability to 
increase mineralisation by osteoblasts in vitro.  
Untreated cells proliferated rapidly up until day 14 followed by a period of extracellular 
matrix development and mineralisation.  This is consistent with previous studies (Stein and 
Lian 1993). A similar trend was observed in Aquamin-cultured cells whereby cell number 
was significantly increased by day 14 and this was followed by a period which saw no 
change in cell proliferation. Interestingly, there were significantly more cells in the control 
group at 21 days than in the Aquamin-cultured cells. However, by day 28 there was no 
significant difference in cell number between the two groups indicating that long term 
exposure of osteoblasts to Aquamin does not have a detrimental effect on osteoblast cell 
number. 
































































Comparison between the treatment and non-treatment groups showed that Aquamin did not 
significantly affect metabolic activity. However, when taken in the context of cell number, 
the reduced cell number at day 21 in the Aquamin-treated group implies that these cells 
were more metabolically active than the untreated cells. As cell number was not 
significantly increased in the day 28 Aquamin treated group, the results suggest the cells 
have stopped proliferating and are undergoing differentiation which is consistent with the 
increase in ALP expression seen at day 21 in Figure 2. 
Differentiation of the pre-osteoblast to a mature phenotype results in the expression of 
ALP, a bone enzyme which has become a hallmark of osteogenesis and mineralisation 
(Simao et al., 2007). While it may seem unusual that ALP expression was increased at days 
3 and 7 in this study, it is important to remember that MC3T3-E1 cells are a partially 
differentiated cell line. Therefore the introduction of these cells to osteogenic factors will 
initiate production of the ALP enzyme. ALP production is also increased prior to mineral 
production by osteoblasts (Stein and Lian 1993). This is reflected in the increased ALP 
expression in the Aquamin treated group at day 21 prior to the increased mineralisation 
which was observed and measured at day 28 in this treatment group.   
Qualitative analysis of mineralisation using Von Kossa staining showed increased 
mineralisation in both groups over time. Mineralisation was located around individual cell 
nodules although no clear differences were seen between groups. Visually, alizarin red S 
staining was able to detect differences between the individual groups by day 21 with more 
mineral visible in the Aquamin-treated cells. However, quantitatively no significant 
differences were measured. Crucially though, Aquamin induced a significant increase in 
































































mineralisation by day 28 which was visible and quantifiable. This represented a 3 fold 
increase in mineralisation when compared to cells which were cultured in the absence of 
Aquamin.  
The lack of strong differences in Von Kossa staining at days 21 and day 28 between groups 
may seem at odds with the alizarin red staining results. However, von Kossa staining is a 
highly specific stain for calcium or calcium salt which primarily stains calcium phosphate 
and calcium carbonate by binding the positive silver ion with the negative phosphate or 
carbonate portion. In cont ast, the alizarin red S stain is a far broader stain that is not 
entirely specific for calcium since magnesium, manganese, barium, strontium and iron may 
be stained during this process (manufacturer’s information). Under normal circumstances 
these elements do not usually occur in sufficient concentrations to affect staining however 
all are present in Aquamin. Therefore, it appears as if these elements are synergistically 
contributing to the amount of mineral deposition occurring in the cell layer. Despite the 
apparent discrepancies, both techniques do show increased mineralisation at the later time 
points and this is in agreement with previous reports where Aquamin was shown to be of 
benefit in bone health (Aslam et al., 2010a; Nielsen et al., 2010). Other marine calcium 
carbonate sources such as nacre (mother of pearl) from Pinctada Maxima also increase 
mineralisation of MC3T3-E1 mouse pre-osteoblasts (Rousseau et al., 2003). 
A number of studies have shown that bone density can be increased with calcium 
supplementation (Karkkainen et al., 2010; Lips et al., 2010). In the current study Aquamin 
was found to significantly increase the mineralisation ability of osteoblasts. In an in vivo 
situation this increased mineralisation would be expected to translate to an increase in bone 
































































density. Whether this is the case will require further study, however, this study has shown 
that Aquamin has a direct effect on the mineralisation capabilities of osteoblasts. In 
previous studies it was hypothesised that Aquamin’s positive effects on bone were a 
secondary response to changes in systemic inflammation. While this may still be the case, 
the current data proves that Aquamin directly influences the bone forming cells.  
There is no doubt that calcium plays an important role in maintaining bone health. 
Although recent research has suggested an increased risk of cardiovascular events in people 
taking high doses of calcium supplements (Bolland et al., 2010).  This increased 
cardiovascular risk does not appear when the calcium is taken in the form of a food 
supplement (Reid et al., 2011). As Aquamin is a natural calcium-rich food none of the 
potential risks associated with high doses of calcium supplementation have been reported. 
This study has a number of limitations one of which is the use of MC3T3 cells, a murine 
immortalised cell line. A primary culture of human osteoblasts may provide a better 
indication of osteoblast cell response. In addition, a more comprehensive analysis of the 
genes and proteins associated with the process of osteogenesis might help our 
understanding of the process by which Aquamin enhances osteoblast activity. Although 
calcium is the most abundant mineral in Aquamin, we do not yet know which of the 
multiple minerals present contribute to the observed effects. However, it is likely that many 
of the components synergistically interact to influence bone structure and function and 
enhance normal mineralisation in osteoblast cells. A potential drawback of this study was 
the use of toluidine blue as a counterstain in the von Kossa staining rather than nuclear fast 
































































red. This dark blue stain makes it difficult to identify the mineralised nodules which appear 
as a dark brown/black colour.  
Despite these limitations, this study has shown qualitatively that Aquamin can directly 
influence osteoblast activity. Where previously it was hypothesised that changes in bone 
metabolism were an indirect response to changes in systemic inflammation this study has 
shown that Aquamin can directly influence osteoblasts to produce more mineral. This study 
does represent the first steps towards understanding how Aquamin improves bone health. 
In summary, although it is accepted that further research in both explants and animals is 
needed, this initial study has demonstrated that Aquamin shows no cytoxicity in osteoblast 
cell culture and increases mineralisation. It may therefore possess significant potential for 
treating bone diseases such as osteoporosis. 
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Figure 1: Effect of Aquamin on metabolic activity (A) and cell number (B) over 28 
days. Cell metabolic activity was determined at 1, 3, 7, 14, 21 and 28 days using 
alamarBlueTM assay (1A). Results are expressed as % reduction (n=6). Error bars represent 
S.D. * = p<0.047 relative to Days 1, 3 and 7.  Cell number was determined using a Hoescht 
DNA assay (1B). Error bars represent S.D. n=3 for each time point. * = p<0.042 relative to 
days 1, 3 and 7. ** = p< 0.05 relative to all other groups and time points. 
Figure 2: Effect of Aquamin on the expression of alkaline phosphatase. Alkaline 
phosphatase expression was determined via a pNPP assay and normalised to cell number. 
Expression was significantly higher in both groups at days 3 and 7 than days 1, 14, 21 and 
28. Normalised ALP expression in the Aquamin treated group was greater than in the 
control group at day 21. Error bars represent S.D. n=3 for each time point. * = p≤0.005 ** 
= p≤0.05. 
Figure 3: Mineralisation staining with Von Kossa. Visualised using 100x magnification 
(A) Control Day 3 (B) Aquamin Day 3 (C) Control Day 7 (D) Aquamin Day 7 (E) Control 
Day 14 (F) Aquamin Day 14.  (G) Control Day 21 (H) Aquamin Day 21 (I) Control Day 28 
(J) Aquamin Day 28. Red arrows indicate cell nodule formation coupled with dark specks 
of the black Von Kossa stain indicated by the yellow arrows.   
Figure 4: Mineralisation staining with Alizarin Red S. (A) Visualised using 100x 
magnification (A) Control Day 3 (B) Aquamin Day 3 (C) Control Day 7 (D) Aquamin Day 
7 (E) Control Day 14 (F) Aquamin Day 14. (G) Control Day 21 (H) Aquamin Day 21 (I) 
Control Day 28 (J) Aquamin Day 28. Black arrows indicate cell nodule formation and 
































































yellow arrows indicate small mineral deposits. (B) Mineral was quantified using alizarin 
red S assay. Error bars represent S.D. n=3. * = p<0.001 relative to all other groups and time 
points. ** = p<0.018 relative to Control and Aquamin at Day 1.   
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